{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:52:15Z","timestamp":1786996335464,"version":"build-2736575974"},"reference-count":64,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Spanish Journal of Psychiatry and Mental Health"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.rpsm.2023.01.005","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T02:26:48Z","timestamp":1675736808000},"page":"239-250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Meta-analysis of the effects of adjuvant drugs in co-occurring bipolar and substance use disorder"],"prefix":"10.1016","volume":"17","author":[{"given":"Joaquim","family":"Radua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Fortea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Manuel","family":"Goikolea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u00f1aki","family":"Zorrilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Arrojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Cunill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavi","family":"Castells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisardo","family":"Beco\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"L\u00f3pez-Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Torrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Tirado-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francina","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"Arranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Garriga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar A.","family":"S\u00e1iz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Fl\u00f3rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"San","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Gonz\u00e1lez-Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpsm.2023.01.005_bib0325","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1590\/1516-4446-2012-1693","article-title":"Bipolar disorder prevalence: a systematic review and meta-analysis of the literature","volume":"37","author":"Clemente","year":"2015","journal-title":"Rev Bras Psiquiatr Sao Paulo Braz"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0330","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.1990.03450190043026","article-title":"Comorbidity of mental disorders with alcohol and other drug abuse: results from the epidemiologic catchment area (ECA) study","volume":"264","author":"Regier","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0335","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.biopsych.2004.06.034","article-title":"The epidemiology of dual diagnosis","volume":"56","author":"Kessler","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0340","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.4088\/JCP.v66n1001","article-title":"Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"66","author":"Grant","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0345","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0165-0327(00)00169-5","article-title":"Drug abuse and bipolar disorder: comorbidity or misdiagnosis?","volume":"65","author":"Sherwood Brown","year":"2001","journal-title":"J Affect Disord"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0350","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1399-5618.2011.00943.x","article-title":"The co-occurrence of cigarette smoking and bipolar disorder: phenomenology and treatment considerations","volume":"13","author":"Heffner","year":"2011","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0355","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1001\/jama.284.20.2606","article-title":"Smoking and mental illness: a population-based prevalence study","volume":"284","author":"Lasser","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0360","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1034\/j.1399-5618.2001.30403.x","article-title":"Substance abuse in bipolar disorder","volume":"3","author":"Cassidy","year":"2001","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0365","doi-asserted-by":"crossref","first-page":"671","DOI":"10.4088\/JCP.09m05483yel","article-title":"Poor long-term prognosis in mixed bipolar patients: 10-year outcomes in the Vitoria prospective naturalistic study in Spain","volume":"72","author":"Gonz\u00e1lez-Pinto","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0370","doi-asserted-by":"crossref","first-page":"733","DOI":"10.4088\/JCP.v60n1103","article-title":"A history of substance abuse complicates remission from acute mania in bipolar disorder","volume":"60","author":"Goldberg","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0375","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00005053-199406000-00007","article-title":"Substance abuse and bipolar affective disorder","volume":"182","author":"Sonne","year":"1994","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0380","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1001\/archpsyc.1990.01810240026005","article-title":"Outcome in Mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis","volume":"47","author":"Tohen","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0385","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1521-0391.1994.tb00246.x","article-title":"Using the general behavior inventory to screen for mood disorders among patients with psychoactive substance dependence","volume":"3","author":"Saxon","year":"1994","journal-title":"Am J Addict"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0390","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1192\/bjp.172.4.345","article-title":"Substance misuse and risk of aggression and offending among the severely mentally ill","volume":"172","author":"Scott","year":"1998","journal-title":"Br J Psychiatry J Ment Sci"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0395","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4088\/JCP.09r05222gry","article-title":"Comorbid substance use disorders among youth with bipolar disorder: opportunities for early identification and prevention","volume":"71","author":"Goldstein","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0400","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/acps.12366","article-title":"Cannabis and bipolar disorder: does quitting cannabis use during manic\/mixed episode improve clinical\/functional outcomes?","volume":"131","author":"Zorrilla","year":"2015","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0405","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.psychres.2012.08.025","article-title":"Working memory as a predictor of negative symptoms and functional outcome in first episode psychosis","volume":"206","author":"Gonz\u00e1lez-Ortega","year":"2013","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0410","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.4088\/JCP.08m04302","article-title":"Neurocognitive dysfunctions in euthymic bipolar patients with and without prior history of alcohol use","volume":"70","author":"Sanchez-Moreno","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0415","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.3390\/jcm11143935","article-title":"Machine learning prediction of comorbid substance use disorders among people with bipolar disorder","volume":"11","author":"Oliva","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0420","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ [Internet]"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0425","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0430","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/archpsyc.1996.01830090023004","article-title":"A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia","volume":"53","author":"Thase","year":"1996","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0435","series-title":"ECDEU assessment manual for psychopharmacology. Rev. 1976","first-page":"603","author":"Guy","year":"1976"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0440","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0445","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"Br J Psychiatry J Ment Sci"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0450","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br J Med Psychol"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0455","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0460","first-page":"17","article-title":"Clinical significance of reversed vegetative subtypes of recurrent major depression","volume":"27","author":"Thase","year":"1991","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0465","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/mpr.79","article-title":"The Inventory of Depressive Symptomatology (IDS): Clinician (IDS-C) and Self-Report (IDS-SR) ratings of depressive symptoms","volume":"9","author":"Rush","year":"2000","journal-title":"Int J Methods Psychiatr Res"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0470","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0475","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0006-3223(02)01866-8","article-title":"The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression","volume":"54","author":"Rush","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0480","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1744-859X-10-2","article-title":"Guidelines for rating Global Assessment of Functioning (GAF)","volume":"10","author":"Aas","year":"2011","journal-title":"Ann Gen Psychiatry"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0485","series-title":"The anxiety disease","first-page":"206","author":"Sheehan","year":"1983"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0490","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1600-0447.1979.tb04484.x","article-title":"The Bech-Rafaelsen Mania Scale and the Hamilton Depression Scale","volume":"59","author":"Bech","year":"1979","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0495","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psychiatry J Ment Sci"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0500","series-title":"Rey auditory verbal learning test: RAVLT: a handbook","first-page":"137","author":"Schmidt","year":"1996"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0505","first-page":"321","article-title":"Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure","volume":"29","author":"Endicott","year":"1993","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0510","first-page":"304","article-title":"The Brief Substance Craving Scale \u2013 measuring craving in clinical trials","volume":"180","author":"Somoza","year":"1999","journal-title":"NIDA Res Monogr"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0515","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0376-8716(93)90042-O","article-title":"The development of a cocaine craving questionnaire","volume":"34","author":"Tiffany","year":"1993","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0520","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/archpsyc.1996.01830030047008","article-title":"The obsessive compulsive drinking scale: a new method of assessing outcome in alcoholism treatment studies","volume":"53","author":"Anton","year":"1996","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0525","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/j.1530-0277.1999.tb04349.x","article-title":"Psychometric properties of the Penn Alcohol Craving Scale","volume":"23","author":"Flannery","year":"1999","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0530","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction \u2013 GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0535","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1002\/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M","article-title":"A simple method for converting an odds ratio to effect size for use in meta-analysis","volume":"19","author":"Chinn","year":"2000","journal-title":"Stat Med"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0540","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.neuroimage.2018.10.077","article-title":"Voxel-based meta-analysis via permutation of subject images (PSI): theory and implementation for SDM","volume":"186","author":"Albajes-Eizagirre","year":"2019","journal-title":"NeuroImage"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0545","doi-asserted-by":"crossref","first-page":"701","DOI":"10.4088\/JCP.v69n0502","article-title":"A randomized, double-blind, placebo-controlled add-on trial of quetiapine in outpatients with bipolar disorder and alcohol use disorders","volume":"69","author":"Brown","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0550","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/JCP.0b013e31814db4c4","article-title":"A randomized, placebo-controlled trial of citicoline add-on therapy in outpatients with bipolar disorder and cocaine dependence","volume":"27","author":"Brown","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0555","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1038\/npp.2012.90","article-title":"A randomized, double-blind, placebo-controlled, trial of lamotrigine therapy in bipolar disorder, depressed or mixed phase and cocaine dependence","volume":"37","author":"Brown","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0560","doi-asserted-by":"crossref","first-page":"765","DOI":"10.4088\/JCP.13m08756","article-title":"Varenicline for smoking cessation in bipolar disorder: a randomized, double-blind, placebo-controlled study","volume":"75","author":"Chengappa","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0565","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1001\/jamapsychiatry.2015.2196","article-title":"Ventral striatal activation during reward processing in psychosis: a neurofunctional meta-analysis","volume":"72","author":"Radua","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0570","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0575","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.schres.2016.11.018","article-title":"Maintenance pharmacotherapy normalizes the relapse curve in recently abstinent tobacco smokers with schizophrenia and bipolar disorder","volume":"183","author":"Evins","year":"2017","journal-title":"Schizophr Res"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0580","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.schres.2016.05.011","article-title":"It is feasible and effective to help patients with severe mental disorders to quit smoking: an ecological pragmatic clinical trial with transdermal nicotine patches and varenicline","volume":"176","author":"Garcia-Portilla","year":"2016","journal-title":"Schizophr Res"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0585","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1007\/s00213-017-4642-5","article-title":"A placebo controlled study of quetiapine-XR in bipolar depression accompanied by generalized anxiety with and without a recent history of alcohol and cannabis use","volume":"234","author":"Gao","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0590","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.psychres.2011.04.030","article-title":"Comorbid anxiety disorders and baseline medication regimens predict clinical outcomes in individuals with co-occurring bipolar disorder and alcohol dependence: results of a randomized controlled trial","volume":"188","author":"Prisciandaro","year":"2011","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0595","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3109\/00952990.2015.1114118","article-title":"An open-label pilot study of icariin for co-morbid bipolar and alcohol use disorder","volume":"42","author":"Xiao","year":"2016","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0600","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/schbul\/sbl010","article-title":"Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram","volume":"32","author":"Petrakis","year":"2005","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0605","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.euroneuro.2020.12.006","article-title":"A randomized, double-blind, placebo-controlled proof-of-concept study of ondansetron for bipolar and related disorders and alcohol use disorder","volume":"43","author":"Sherwood Brown","year":"2021","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0610","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archpsyc.62.1.37","article-title":"Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study","volume":"62","author":"Salloum","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0615","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000449417","article-title":"Meta-analysis of the risk of subsequent mood episodes in bipolar disorder","volume":"86","author":"Radua","year":"2017","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0620","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1111\/j.1530-0277.2009.01024.x","article-title":"A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence","volume":"33","author":"Brown","year":"2009","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0625","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1111\/acer.12445","article-title":"A randomized, double-blind, placebo-controlled trial of quetiapine in patients with bipolar disorder, mixed or depressed phase, and alcohol dependence","volume":"38","author":"Brown","year":"2014","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0630","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1111\/j.1530-0277.2010.01270.x","article-title":"A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence: quetiapine in bipolar disorder and alcohol dependence","volume":"34","author":"Stedman","year":"2010","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0635","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/ajad.12346","article-title":"A randomized, placebo-controlled proof-of-concept trial of adjunctive topiramate for alcohol use disorders in bipolar disorder: efficacy of topiramate","volume":"25","author":"Sylvia","year":"2016","journal-title":"Am J Addict"},{"key":"10.1016\/j.rpsm.2023.01.005_bib0640","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jad.2019.06.008","article-title":"Safety and efficacy of first-line smoking cessation pharmacotherapies in bipolar disorders: subgroup analysis of a randomized clinical trial","volume":"256","author":"Heffner","year":"2019","journal-title":"J Affect Disord"}],"container-title":["Spanish Journal of Psychiatry and Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S188898912300006X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S188898912300006X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T18:19:32Z","timestamp":1759429172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S188898912300006X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S188898912300006X"],"URL":"https:\/\/doi.org\/10.1016\/j.rpsm.2023.01.005","relation":{},"ISSN":["2950-2853"],"issn-type":[{"value":"2950-2853","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meta-analysis of the effects of adjuvant drugs in co-occurring bipolar and substance use disorder","name":"articletitle","label":"Article Title"},{"value":"Spanish Journal of Psychiatry and Mental Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpsm.2023.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 SEP y SEPB. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}